The surprising discovery of bitter taste receptors in human lungs could revolutionize the treatment of asthma and other obstructive lung diseases, according to researchers at the University of ...

The novel radiotracer ¹⁸F-FAPI-RGD in PET/CT scans shows potential for diagnosing ILD in connective tissue disease patients by highlighting fibroblast activation and tissue remodeling. Patients with ...

Humans have bitter taste receptors not only in their mouths but in their lungs, too. Researchers have exploited these receptors’ innate ability to dilate the airways to create a potent new drug that ...

Activating the vitamin D receptor shows promise in controlling harmful cell growth linked to pulmonary hypertension, a major factor in disease progression and patient prognosis. Study: Vitamin D ...

The National Institute for Health and Care Excellence (NICE) has recommended amivantamab (Rybrevant) plus lazertinib (Lazcluze) as a first-line option for adults with previously untreated advanced non ...

G protein-coupled receptors (GPCRs) constitute one of the largest families of membrane receptors, playing pivotal roles in cellular communication and signal transduction. In lung cancer, emerging ...

The ability to taste isn’t limited to the mouth, and researchers say that discovery might one day lead to better treatments for diseases such as asthma. It turns out that receptors for bitter tastes ...

University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body. This protein, the leucine-rich ...

University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body. This protein, the leucine-rich ...

The University of Cincinnati's Debanjan Bhattacharya is first author of new research published in Cancers that found the drug AM-101 improves the effectiveness and survival rate of radiation treatment ...

Researchers have developed an inhalable RNA-based drug that targets the overactive white blood cells that cause lung damage during severe infection, reducing inflammation and scarring. With human ...